To Thwart “Lab Shopping,” Regulators Announce “One Sample, One CoA” Policy
Massachusetts cannabis stakeholders say new CCC action is a small step toward stopping laboratory fraud, but nonetheless movement in the right direction
Massachusetts cannabis stakeholders say new CCC action is a small step toward stopping laboratory fraud, but nonetheless movement in the right direction
Body passes recommendation for Cannabis Control Commission to “prioritize previous [Cannabis Advisory Board] recommendations”
The Massachusetts Cannabis Control Commission is considering changes to improve laboratory integrity and prevent fraud. But stakeholders say the agency is missing the big picture.
“Either regulators step in and solve this problem, as we have seen in multiple states, or honest labs go out of business.”
Multistate data set enables researchers to explore failure rates by strain across the country
Massachusetts has a cannabis fraud problem, and not just in terms of inflated potency
“This letter responds to inquiries received by the Commission and provides clarification regarding the agency’s timelines for implementation.”
“The study is launching at a time of crisis and need for innovations to address the growing opioid epidemic and its intersection with a growing homelessness crisis in Massachusetts.”
“We want this event to bridge the gap between academic researchers, industry innovators, legislators, and your average consumer.”
Following embarrassing complaints from scientists and stakeholders about weak standards for measuring potency, Massachusetts Cannabis Control Commission publishes new guidance document
View this profile on InstagramTalking Joints Memo (@tjmlive) • Instagram photos and videos
Sign up for Talking Joints Memo newsletter